Navigation Links
An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes

CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - New data from an investigational study released at the American Diabetes Association (ADA) 67th Annual Scientific Sessions showed that initial combination therapy with Januvia(TM) (sitagliptin) and metformin demonstrated significant improvement in markers of beta cell function in patients with type 2 diabetes. Pancreatic islet beta cell function determines the ability of the body to produce insulin, a hormone which plays a central role in the regulation of blood sugar levels. New data from a separate pharmacologic study reported today in an oral presentation revealed that, when used in combination in healthy adults, the different mechanisms of action of JANUVIA and metformin had a complementary effect on glucagon-like peptide-1 (GLP-1) levels, another hormone that is an important regulator of blood sugar levels. This aspect of the mechanism of action of metformin used in combination with JANUVIA was previously unknown. GLP-1 acts, in part, by enhancing pancreatic beta cell insulin production and secretion.

JANUVIA is a selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances a natural body system, called the incretin system, which helps to regulate glucose by affecting the beta cells and alpha cells in the pancreas. JANUVIA is the first and only DPP-4 inhibitor to be approved and marketed in the United States for patients with type 2 diabetes. JANUVIA is indicated, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus. JANUVIA is also indicated to improve glycemic control, in combination with metformin or a thiazolidinedione (TZD), in patients with type 2 diabetes when the single agent alone plus diet and exercise do not provide adequate glycemic control. JANUVIA should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these se
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:12/22/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ) ... Analysis of the US Medical Device Sector " ... http://photos.prnewswire.com/prnh/20130307/600769 This analysis ... identifies the key trends and rationale for undertaking ... and acquisitions. The study will be ...
(Date:12/22/2014)... , Dec. 22, 2014 Swedish Orphan ... today announced that the Committee for Medicinal Products for ... has adopted a positive opinion for the use of ... men with Peyronie,s disease with a palpable plaque and ... start of therapy. The use of Xiapex ...
(Date:12/22/2014)... Dec, 22, 2014  Eiger BioPharmaceuticals Incorporated announced ... of lonafarnib in patients with chronic hepatitis delta ... the National Institutes of Health (NIH) Clinical Center ... double-blinded, randomized, placebo-controlled, dose ascending study evaluated two ... 200 mg twice daily for 28 days.  "This ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... With many young school athletes working ... USA is hosting Youth Sports Safety Clinics across ... keep children safe and prevent sports injuries, including heat-related illnesses. ... who plays organized sports.  Unfortunately, about 3.5 million children receive ...
... 3, 2011 BioMed Realty Trust, Inc. (NYSE: ... Real Estate to the Life Science Industry®, today announced financial ... Second Quarter 2011 Highlights Generated ... million, up 14.9% from $92.9 million in the same period ...
Cached Medicine Technology:Young School Athletes at Risk for Sports-Related Injuries, Including Heat Stroke 2Young School Athletes at Risk for Sports-Related Injuries, Including Heat Stroke 3Young School Athletes at Risk for Sports-Related Injuries, Including Heat Stroke 4Young School Athletes at Risk for Sports-Related Injuries, Including Heat Stroke 5BioMed Realty Trust Reports Second Quarter 2011 Financial Results 2BioMed Realty Trust Reports Second Quarter 2011 Financial Results 3BioMed Realty Trust Reports Second Quarter 2011 Financial Results 4BioMed Realty Trust Reports Second Quarter 2011 Financial Results 5BioMed Realty Trust Reports Second Quarter 2011 Financial Results 6BioMed Realty Trust Reports Second Quarter 2011 Financial Results 7BioMed Realty Trust Reports Second Quarter 2011 Financial Results 8BioMed Realty Trust Reports Second Quarter 2011 Financial Results 9BioMed Realty Trust Reports Second Quarter 2011 Financial Results 10BioMed Realty Trust Reports Second Quarter 2011 Financial Results 11BioMed Realty Trust Reports Second Quarter 2011 Financial Results 12BioMed Realty Trust Reports Second Quarter 2011 Financial Results 13
(Date:12/25/2014)... News) -- The risk of burns from fires and ... to be extra cautious, an expert says. "Between ... increase in patients coming in with burns," said Dr. ... Firefighters Burn Center of Stony Brook University Hospital in ... joy, but if not careful, could quickly turn tragic," ...
(Date:12/25/2014)... WEDNESDAY, Dec. 24, 2014 (HealthDay News) -- Among early ... treatment, less than half of one percent will eventually ... new analysis reveals. The finding comes from a ... between 1998 and 2007, and it suggests that the ... double what experts had previously thought. "The frequency ...
(Date:12/25/2014)... 2014 AngelWeddingDress.com tries its best to ... realm. Today, the business has introduced its new collection ... dress promotion. , The new prom outfits are guaranteed ... dress lover. They are specially designed for 2015. Anyone ... dresses should visit its website before Jan. 26, 2015, ...
(Date:12/25/2014)... December 25, 2014 “ SmileStix ” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review and shared ... create personal stickers. , The old saying goes, “A picture ... of words that can describe a single image, because each ...
(Date:12/25/2014)... 25, 2014 Residents at ... recently showed their generous spirit by providing holiday ... County Parenting Network- Grandparents Raising Grandchildren program. , ... around the largest Christmas tree on the campus ... by residents of the Abernethy Village Association (AVA). ...
Breaking Medicine News(10 mins):Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Retirement Community Residents Make Impact During Holiday Season 2
... Minn., July 7 The Institute for Clinical Systems Improvement ... explain how its DIAMOND program is dramatically improving patient outcomes ... , , The DIAMOND program changes how care for ... primary care settings. The symposium will focus on the 18-month ...
... look at the relatives reveals clues about course of illness, ... A person,s family history not only reveals their risk for ... it may also predict the course of the illness and ... residents of Dunedin, New Zealand, who were enrolled at age ...
... regulation of gun sellers appears to reduce the trafficking ... by researchers at the Johns Hopkins Bloomberg School of ... is important because 85 percent of guns recovered by ... the original purchasers of the guns according to prior ...
... Cardiovascular diseases (CVD) are the main cause of early death ... of more than 2 million lives and costing the EU ... and national policymakers are meeting in Brussels to assess current ... The one day conference, organised by the European ...
... than five and a half pounds at birth often ... including respiratory problems. New research shows that these respiratory ... and into adulthood. "We report a previously ... young adults with a history of low birth weight," ...
... Per member administrative costs grew by 11.5% in 2008, ... in product mix towards Medicare Advantage, administrative expense growth ... By contrast, administrative expenses were 8.3% of premium equivalents ... reported total administrative expenses of $30.37 per member per ...
Cached Medicine News:Health News:ICSI Plans Symposium on New Depression Treatment Program That Is Improving Patient Outcomes Five-Fold Over Typical Primary Care 2Health News:Family History Key to Psychiatric Disorder Risk 2Health News:Regulation and oversight of gun sales reduces trafficking to criminals 2Health News:Regulation and oversight of gun sales reduces trafficking to criminals 3Health News:Low birth weight linked to long-term respiratory problems 2Health News:Low birth weight linked to long-term respiratory problems 3Health News:Independent / Provider-Sponsored Administrative Cost Trends Increase in 2008 as Ratios Decrease on Product Mix Change 2
Inquire...
The latest VALENTINO eyewear collection is a refined expression of sophisticated luxury,balancing ultimate feminine, chic styles against understated, minimalist mens models....
The Nine West Eyewear collection is positioned to present today's styles with a sharp, edgy contemporary attitude tied into a clean design element....
The Liz Claiborne eyewear collection features feminine, classic, progressive friendly designs that meet the needs of today's women. The high quality frames are modern, but not trendy....
Medicine Products: